Baxter declares quarterly dividend of $0.335 per common share

The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.335 per Baxter common share.

The dividend is payable on July 2, 2012 to shareholders of record as of June 8, 2012.

Over the last five years, Baxter has consistently grown its dividends for shareholders, more than doubling the rate during this period. In total, the company has returned approximately $11.4 billion to shareholders over the last five years in the form of dividends and share repurchases.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Baxter International Inc.. (2019, June 19). Baxter declares quarterly dividend of $0.335 per common share. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20120508/Baxter-declares-quarterly-dividend-of-240335-per-common-share.aspx.

  • MLA

    Baxter International Inc.. "Baxter declares quarterly dividend of $0.335 per common share". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20120508/Baxter-declares-quarterly-dividend-of-240335-per-common-share.aspx>.

  • Chicago

    Baxter International Inc.. "Baxter declares quarterly dividend of $0.335 per common share". News-Medical. https://www.news-medical.net/news/20120508/Baxter-declares-quarterly-dividend-of-240335-per-common-share.aspx. (accessed November 23, 2024).

  • Harvard

    Baxter International Inc.. 2019. Baxter declares quarterly dividend of $0.335 per common share. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20120508/Baxter-declares-quarterly-dividend-of-240335-per-common-share.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baxter reports positive results from BAX 855 Phase 3 trial for hemophilia A